nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—PTGS1—Alzheimer's disease	0.434	1	CbGaD
Ketobemidone—CYP2B6—Memantine—Alzheimer's disease	0.142	0.306	CbGbCtD
Ketobemidone—CYP2C19—Memantine—Alzheimer's disease	0.0903	0.194	CbGbCtD
Ketobemidone—CYP2C9—Donepezil—Alzheimer's disease	0.0866	0.186	CbGbCtD
Ketobemidone—CYP3A4—Rivastigmine—Alzheimer's disease	0.063	0.135	CbGbCtD
Ketobemidone—CYP3A4—Donepezil—Alzheimer's disease	0.0503	0.108	CbGbCtD
Ketobemidone—CYP3A4—Galantamine—Alzheimer's disease	0.0324	0.0698	CbGbCtD
Ketobemidone—OPRM1—telencephalic ventricle—Alzheimer's disease	0.00511	0.187	CbGeAlD
Ketobemidone—Pethidine—GRIN2B—Alzheimer's disease	0.00283	0.624	CrCbGaD
Ketobemidone—OPRD1—forebrain—Alzheimer's disease	0.00196	0.0716	CbGeAlD
Ketobemidone—OPRK1—forebrain—Alzheimer's disease	0.00188	0.0686	CbGeAlD
Ketobemidone—OPRD1—telencephalon—Alzheimer's disease	0.0018	0.0658	CbGeAlD
Ketobemidone—OPRM1—forebrain—Alzheimer's disease	0.00133	0.0488	CbGeAlD
Ketobemidone—PTGS1—blood vessel—Alzheimer's disease	0.00123	0.0451	CbGeAlD
Ketobemidone—OPRM1—telencephalon—Alzheimer's disease	0.00123	0.0449	CbGeAlD
Ketobemidone—OPRD1—nervous system—Alzheimer's disease	0.00106	0.0389	CbGeAlD
Ketobemidone—OPRD1—central nervous system—Alzheimer's disease	0.00102	0.0374	CbGeAlD
Ketobemidone—OPRK1—nervous system—Alzheimer's disease	0.00102	0.0373	CbGeAlD
Ketobemidone—Pethidine—SLC6A4—Alzheimer's disease	0.000999	0.221	CrCbGaD
Ketobemidone—OPRK1—central nervous system—Alzheimer's disease	0.00098	0.0359	CbGeAlD
Ketobemidone—OPRK1—cerebellum—Alzheimer's disease	0.000958	0.0351	CbGeAlD
Ketobemidone—OPRD1—brain—Alzheimer's disease	0.000812	0.0297	CbGeAlD
Ketobemidone—OPRK1—brain—Alzheimer's disease	0.000778	0.0285	CbGeAlD
Ketobemidone—OPRM1—nervous system—Alzheimer's disease	0.000724	0.0265	CbGeAlD
Ketobemidone—Pethidine—CYP2D6—Alzheimer's disease	0.000702	0.155	CrCbGaD
Ketobemidone—OPRM1—central nervous system—Alzheimer's disease	0.000697	0.0255	CbGeAlD
Ketobemidone—PTGS1—forebrain—Alzheimer's disease	0.000651	0.0238	CbGeAlD
Ketobemidone—PTGS1—telencephalon—Alzheimer's disease	0.000598	0.0219	CbGeAlD
Ketobemidone—OPRM1—brain—Alzheimer's disease	0.000554	0.0203	CbGeAlD
Ketobemidone—CYP2B6—nervous system—Alzheimer's disease	0.000391	0.0143	CbGeAlD
Ketobemidone—CYP2B6—central nervous system—Alzheimer's disease	0.000376	0.0138	CbGeAlD
Ketobemidone—PTGS1—nervous system—Alzheimer's disease	0.000353	0.0129	CbGeAlD
Ketobemidone—PTGS1—central nervous system—Alzheimer's disease	0.00034	0.0124	CbGeAlD
Ketobemidone—CYP2C8—brain—Alzheimer's disease	0.000333	0.0122	CbGeAlD
Ketobemidone—CYP2B6—brain—Alzheimer's disease	0.000299	0.0109	CbGeAlD
Ketobemidone—CYP3A4—nervous system—Alzheimer's disease	0.000295	0.0108	CbGeAlD
Ketobemidone—CYP3A4—central nervous system—Alzheimer's disease	0.000284	0.0104	CbGeAlD
Ketobemidone—PTGS1—brain—Alzheimer's disease	0.00027	0.00988	CbGeAlD
Ketobemidone—OPRK1—Signaling Pathways—IGF2—Alzheimer's disease	1.64e-05	0.000234	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—MAOB—Alzheimer's disease	1.63e-05	0.000234	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ABCA1—Alzheimer's disease	1.63e-05	0.000233	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCR5—Alzheimer's disease	1.59e-05	0.000228	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.59e-05	0.000228	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IGF1R—Alzheimer's disease	1.58e-05	0.000227	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NGFR—Alzheimer's disease	1.57e-05	0.000225	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	1.57e-05	0.000225	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—LPL—Alzheimer's disease	1.57e-05	0.000225	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CREB1—Alzheimer's disease	1.56e-05	0.000224	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HTR2A—Alzheimer's disease	1.56e-05	0.000223	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ACHE—Alzheimer's disease	1.56e-05	0.000223	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.55e-05	0.000223	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—INPP5D—Alzheimer's disease	1.54e-05	0.000221	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.54e-05	0.00022	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ADAM10—Alzheimer's disease	1.54e-05	0.00022	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CCL2—Alzheimer's disease	1.53e-05	0.000219	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.53e-05	0.000219	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—TPI1—Alzheimer's disease	1.52e-05	0.000218	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CHAT—Alzheimer's disease	1.52e-05	0.000218	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—A2M—Alzheimer's disease	1.52e-05	0.000217	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—LPL—Alzheimer's disease	1.52e-05	0.000217	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.51e-05	0.000216	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MEF2C—Alzheimer's disease	1.5e-05	0.000215	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PRKCG—Alzheimer's disease	1.47e-05	0.000211	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.47e-05	0.00021	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTGS1—Alzheimer's disease	1.46e-05	0.000209	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ENO1—Alzheimer's disease	1.46e-05	0.000209	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—MAOB—Alzheimer's disease	1.46e-05	0.000209	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CALM1—Alzheimer's disease	1.45e-05	0.000208	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—S100B—Alzheimer's disease	1.45e-05	0.000208	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—LEP—Alzheimer's disease	1.45e-05	0.000208	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—APOE—Alzheimer's disease	1.45e-05	0.000208	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NGF—Alzheimer's disease	1.44e-05	0.000206	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CAV1—Alzheimer's disease	1.44e-05	0.000206	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP2D6—Alzheimer's disease	1.43e-05	0.000205	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.42e-05	0.000203	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—MTHFR—Alzheimer's disease	1.41e-05	0.000202	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PPARGC1A—Alzheimer's disease	1.4e-05	0.000201	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	1.4e-05	0.000201	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCR5—Alzheimer's disease	1.4e-05	0.0002	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—HMOX1—Alzheimer's disease	1.4e-05	0.0002	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.39e-05	0.000199	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.39e-05	0.000199	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.39e-05	0.000199	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ESR1—Alzheimer's disease	1.38e-05	0.000198	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IGF2—Alzheimer's disease	1.38e-05	0.000198	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.37e-05	0.000197	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HTR2A—Alzheimer's disease	1.37e-05	0.000196	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—F2—Alzheimer's disease	1.37e-05	0.000196	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—BCHE—Alzheimer's disease	1.36e-05	0.000195	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—A2M—Alzheimer's disease	1.35e-05	0.000194	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.35e-05	0.000194	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.34e-05	0.000192	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IGF1R—Alzheimer's disease	1.34e-05	0.000192	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.33e-05	0.00019	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ACHE—Alzheimer's disease	1.32e-05	0.000189	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CALM1—Alzheimer's disease	1.32e-05	0.000189	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—APOE—Alzheimer's disease	1.31e-05	0.000188	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	1.31e-05	0.000187	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CAV1—Alzheimer's disease	1.3e-05	0.000186	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PLCB1—Alzheimer's disease	1.28e-05	0.000184	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—LPL—Alzheimer's disease	1.28e-05	0.000184	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1.28e-05	0.000183	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—LPL—Alzheimer's disease	1.28e-05	0.000183	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CALM1—Alzheimer's disease	1.28e-05	0.000183	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—LEP—Alzheimer's disease	1.27e-05	0.000182	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—APOE—Alzheimer's disease	1.27e-05	0.000182	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MEF2C—Alzheimer's disease	1.27e-05	0.000182	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.26e-05	0.000181	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CAV1—Alzheimer's disease	1.26e-05	0.00018	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—GSK3B—Alzheimer's disease	1.26e-05	0.00018	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.25e-05	0.000179	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PRKCG—Alzheimer's disease	1.25e-05	0.000179	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CREB1—Alzheimer's disease	1.25e-05	0.000178	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ABCA1—Alzheimer's disease	1.24e-05	0.000178	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—INS—Alzheimer's disease	1.24e-05	0.000177	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ENO1—Alzheimer's disease	1.24e-05	0.000177	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	1.24e-05	0.000177	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—A2M—Alzheimer's disease	1.24e-05	0.000177	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCL2—Alzheimer's disease	1.22e-05	0.000175	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NGF—Alzheimer's disease	1.21e-05	0.000174	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ESR1—Alzheimer's disease	1.21e-05	0.000174	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	1.21e-05	0.000174	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.21e-05	0.000173	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—F2—Alzheimer's disease	1.2e-05	0.000172	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IGF1—Alzheimer's disease	1.2e-05	0.000172	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCR5—Alzheimer's disease	1.18e-05	0.000169	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ACHE—Alzheimer's disease	1.18e-05	0.000169	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.17e-05	0.000168	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	1.16e-05	0.000167	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HTR2A—Alzheimer's disease	1.16e-05	0.000166	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—MTHFR—Alzheimer's disease	1.15e-05	0.000165	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—BCHE—Alzheimer's disease	1.15e-05	0.000165	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PPARG—Alzheimer's disease	1.14e-05	0.000164	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—INS—Alzheimer's disease	1.12e-05	0.000161	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ENO1—Alzheimer's disease	1.1e-05	0.000158	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	1.1e-05	0.000158	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.1e-05	0.000158	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—GSK3B—Alzheimer's disease	1.1e-05	0.000158	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CREB1—Alzheimer's disease	1.09e-05	0.000156	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NOS3—Alzheimer's disease	1.09e-05	0.000156	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—INS—Alzheimer's disease	1.09e-05	0.000156	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	1.09e-05	0.000155	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	1.08e-05	0.000155	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CALM1—Alzheimer's disease	1.08e-05	0.000154	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CALM1—Alzheimer's disease	1.07e-05	0.000154	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ACHE—Alzheimer's disease	1.07e-05	0.000154	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—LEP—Alzheimer's disease	1.07e-05	0.000154	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—APOE—Alzheimer's disease	1.07e-05	0.000154	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—APOE—Alzheimer's disease	1.07e-05	0.000153	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PPARGC1A—Alzheimer's disease	1.07e-05	0.000153	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCL2—Alzheimer's disease	1.07e-05	0.000153	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—HMOX1—Alzheimer's disease	1.07e-05	0.000153	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.06e-05	0.000152	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CAV1—Alzheimer's disease	1.06e-05	0.000152	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	1.06e-05	0.000152	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CAV1—Alzheimer's disease	1.06e-05	0.000152	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	1.05e-05	0.000151	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IGF1—Alzheimer's disease	1.05e-05	0.00015	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—BCHE—Alzheimer's disease	1.03e-05	0.000147	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ESR1—Alzheimer's disease	1.03e-05	0.000147	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—F2—Alzheimer's disease	1.01e-05	0.000145	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ENO1—Alzheimer's disease	1.01e-05	0.000144	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	1.01e-05	0.000144	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	9.92e-06	0.000142	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	9.87e-06	0.000141	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—NOS3—Alzheimer's disease	9.84e-06	0.000141	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—LPL—Alzheimer's disease	9.75e-06	0.00014	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	9.69e-06	0.000139	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NOS3—Alzheimer's disease	9.52e-06	0.000136	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	9.5e-06	0.000136	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	9.39e-06	0.000134	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—BCHE—Alzheimer's disease	9.36e-06	0.000134	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PPARG—Alzheimer's disease	9.33e-06	0.000134	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	9.31e-06	0.000133	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—GSK3B—Alzheimer's disease	9.3e-06	0.000133	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CREB1—Alzheimer's disease	9.23e-06	0.000132	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CASP3—Alzheimer's disease	9.22e-06	0.000132	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—INS—Alzheimer's disease	9.18e-06	0.000131	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—IL6—Alzheimer's disease	9.16e-06	0.000131	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—INS—Alzheimer's disease	9.15e-06	0.000131	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CHAT—Alzheimer's disease	9.14e-06	0.000131	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—TPI1—Alzheimer's disease	9.14e-06	0.000131	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	9.07e-06	0.00013	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCL2—Alzheimer's disease	9.03e-06	0.000129	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	9.03e-06	0.000129	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PTGS2—Alzheimer's disease	9e-06	0.000129	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IGF1—Alzheimer's disease	8.88e-06	0.000127	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	8.83e-06	0.000127	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—MTHFR—Alzheimer's disease	8.78e-06	0.000126	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—MAOB—Alzheimer's disease	8.76e-06	0.000126	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	8.66e-06	0.000124	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	8.56e-06	0.000123	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MAPK8—Alzheimer's disease	8.47e-06	0.000121	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—AKT1—Alzheimer's disease	8.45e-06	0.000121	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	8.43e-06	0.000121	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—LPL—Alzheimer's disease	8.25e-06	0.000118	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CALM1—Alzheimer's disease	8.2e-06	0.000117	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—APOE—Alzheimer's disease	8.17e-06	0.000117	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—AKT1—Alzheimer's disease	8.16e-06	0.000117	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—A2M—Alzheimer's disease	8.15e-06	0.000117	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CAV1—Alzheimer's disease	8.1e-06	0.000116	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	8.09e-06	0.000116	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CASP3—Alzheimer's disease	8.09e-06	0.000116	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	8.06e-06	0.000115	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NOS3—Alzheimer's disease	8.05e-06	0.000115	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—IL6—Alzheimer's disease	8.03e-06	0.000115	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—NOS3—Alzheimer's disease	8.02e-06	0.000115	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—VEGFA—Alzheimer's disease	7.82e-06	0.000112	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	7.43e-06	0.000106	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MAPK8—Alzheimer's disease	7.43e-06	0.000106	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—AKT1—Alzheimer's disease	7.41e-06	0.000106	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	7.38e-06	0.000106	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—LPL—Alzheimer's disease	7.37e-06	0.000106	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	7.35e-06	0.000105	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PTGS2—Alzheimer's disease	7.34e-06	0.000105	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TGFB1—Alzheimer's disease	7.18e-06	0.000103	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PPARG—Alzheimer's disease	7.12e-06	0.000102	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ACHE—Alzheimer's disease	7.09e-06	0.000102	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	7e-06	0.0001	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—INS—Alzheimer's disease	6.98e-06	0.0001	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CALM1—Alzheimer's disease	6.94e-06	9.95e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—APOE—Alzheimer's disease	6.92e-06	9.91e-05	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	6.9e-06	9.88e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—VEGFA—Alzheimer's disease	6.86e-06	9.83e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CAV1—Alzheimer's disease	6.86e-06	9.82e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CASP3—Alzheimer's disease	6.83e-06	9.79e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—IL6—Alzheimer's disease	6.79e-06	9.73e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—LPL—Alzheimer's disease	6.72e-06	9.62e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ENO1—Alzheimer's disease	6.64e-06	9.51e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	6.64e-06	9.51e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	6.63e-06	9.5e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	6.51e-06	9.33e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TGFB1—Alzheimer's disease	6.3e-06	9.02e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MAPK8—Alzheimer's disease	6.28e-06	9e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—AKT1—Alzheimer's disease	6.26e-06	8.97e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CALM1—Alzheimer's disease	6.2e-06	8.88e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—APOE—Alzheimer's disease	6.18e-06	8.85e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—BCHE—Alzheimer's disease	6.17e-06	8.84e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—NOS3—Alzheimer's disease	6.12e-06	8.77e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CAV1—Alzheimer's disease	6.12e-06	8.76e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	6.05e-06	8.66e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PPARG—Alzheimer's disease	6.03e-06	8.63e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TP53—Alzheimer's disease	5.91e-06	8.47e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—INS—Alzheimer's disease	5.91e-06	8.47e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	5.83e-06	8.34e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—VEGFA—Alzheimer's disease	5.8e-06	8.31e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CALM1—Alzheimer's disease	5.65e-06	8.09e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	5.65e-06	8.09e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—APOE—Alzheimer's disease	5.63e-06	8.07e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	5.6e-06	8.02e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CAV1—Alzheimer's disease	5.58e-06	7.99e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL6—Alzheimer's disease	5.41e-06	7.75e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PPARG—Alzheimer's disease	5.38e-06	7.71e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TGFB1—Alzheimer's disease	5.32e-06	7.62e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—INS—Alzheimer's disease	5.28e-06	7.56e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TP53—Alzheimer's disease	5.18e-06	7.43e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—NOS3—Alzheimer's disease	5.18e-06	7.43e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—AKT1—Alzheimer's disease	4.99e-06	7.15e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PPARG—Alzheimer's disease	4.9e-06	7.03e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	4.87e-06	6.97e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	4.84e-06	6.94e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—INS—Alzheimer's disease	4.81e-06	6.89e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL6—Alzheimer's disease	4.75e-06	6.8e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	4.74e-06	6.79e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—NOS3—Alzheimer's disease	4.63e-06	6.63e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—AKT1—Alzheimer's disease	4.53e-06	6.48e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—LPL—Alzheimer's disease	4.43e-06	6.35e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TP53—Alzheimer's disease	4.38e-06	6.28e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—AKT1—Alzheimer's disease	4.38e-06	6.27e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	4.23e-06	6.06e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—NOS3—Alzheimer's disease	4.22e-06	6.04e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL6—Alzheimer's disease	4.01e-06	5.75e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.99e-06	5.71e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	3.86e-06	5.53e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CALM1—Alzheimer's disease	3.73e-06	5.34e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—APOE—Alzheimer's disease	3.71e-06	5.32e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AKT1—Alzheimer's disease	3.7e-06	5.3e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—AKT1—Alzheimer's disease	3.69e-06	5.28e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CAV1—Alzheimer's disease	3.68e-06	5.27e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PPARG—Alzheimer's disease	3.23e-06	4.63e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—INS—Alzheimer's disease	3.17e-06	4.54e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—AKT1—Alzheimer's disease	2.81e-06	4.03e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.78e-06	3.99e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.54e-06	3.65e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—AKT1—Alzheimer's disease	2.38e-06	3.41e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—AKT1—Alzheimer's disease	2.13e-06	3.05e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.94e-06	2.78e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.28e-06	1.83e-05	CbGpPWpGaD
